These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
627 related articles for article (PubMed ID: 25745368)
21. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children. Kyvsgaard N; Mikkelsen TS; Thastum M; Christensen AE; Wehner PS; Nysom K; Herlin T PLoS One; 2019; 14(7):e0219539. PubMed ID: 31295288 [TBL] [Abstract][Full Text] [Related]
22. The role of liver transaminase levels in methotrexate intolerance in juvenile idiopathic arthritis-a cross-sectional study. Wibrand C; Kyvsgaard N; Christensen AE; Herlin T Rheumatol Int; 2023 May; 43(5):875-880. PubMed ID: 36922416 [TBL] [Abstract][Full Text] [Related]
23. Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis. Geikowski T; Becker I; Horneff G; Rheumatology (Oxford); 2014 Jul; 53(7):1245-9. PubMed ID: 24599916 [TBL] [Abstract][Full Text] [Related]
24. Perceptions of Methotrexate Intolerance and Its Impact on Daily Life in School-Age Children with Juvenile Idiopathic Arthritis. Khan S; Mancini J; Hopper C; Rennick JE J Pediatr Nurs; 2019; 48():49-54. PubMed ID: 31254860 [TBL] [Abstract][Full Text] [Related]
25. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis. Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908 [TBL] [Abstract][Full Text] [Related]
26. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein. Moncrieffe H; Ursu S; Holzinger D; Patrick F; Kassoumeri L; Wade A; Roth J; Wedderburn LR Rheumatology (Oxford); 2013 Aug; 52(8):1467-76. PubMed ID: 23620557 [TBL] [Abstract][Full Text] [Related]
27. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine? Roszkiewicz J; Smolewska E Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333 [TBL] [Abstract][Full Text] [Related]
28. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. Ravelli A; Viola S; Migliavacca D; Ruperto N; Pistorio A; Martini A J Pediatr; 1999 Sep; 135(3):316-20. PubMed ID: 10484796 [TBL] [Abstract][Full Text] [Related]
29. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry. Foeldvari I; Becker I; Horneff G Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824 [TBL] [Abstract][Full Text] [Related]
30. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. Hawwa AF; AlBawab A; Rooney M; Wedderburn LR; Beresford MW; McElnay JC Arthritis Res Ther; 2015 Oct; 17():295. PubMed ID: 26493320 [TBL] [Abstract][Full Text] [Related]
31. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155 [TBL] [Abstract][Full Text] [Related]
32. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257 [TBL] [Abstract][Full Text] [Related]
33. Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA. Klotsche J; Minden K; Niewerth M; Horneff G Ann Rheum Dis; 2018 Jul; 77(7):996-1002. PubMed ID: 29453217 [TBL] [Abstract][Full Text] [Related]
34. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis. Ortiz-Alvarez O; Morishita K; Avery G; Green J; Petty RE; Tucker LB; Malleson PN; Cabral DA J Rheumatol; 2004 Dec; 31(12):2501-6. PubMed ID: 15570658 [TBL] [Abstract][Full Text] [Related]
35. The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study. Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E Int J Rheum Dis; 2020 Nov; 23(11):1505-1513. PubMed ID: 32969158 [TBL] [Abstract][Full Text] [Related]
36. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618 [TBL] [Abstract][Full Text] [Related]
37. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559 [TBL] [Abstract][Full Text] [Related]
38. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy. Chang CY; Meyer RM; Reiff AO Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674 [TBL] [Abstract][Full Text] [Related]
39. Assessing methotrexate intolerance and its prevalence in rheumatoid arthritis: Development and validation of the MISA questionnaire. Vijaykumar D; Dhir V; Jain S; Pai V; Kaur J; Naidu GS; Sharma A; Khanna Sharma S; Jain S Int J Rheum Dis; 2021 Oct; 24(10):1294-1301. PubMed ID: 34432365 [TBL] [Abstract][Full Text] [Related]
40. The use of methotrexate in children with rheumatic diseases. Gutiérrez-Suárez R; Burgos-Vargas R Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]